US5334534AExpiredUtility

Enzymatic preparation of optically active propanolol and β-adrenergic blockers using esterase

Assignee: RHODE ISLAND EDUCATIONPriority: Apr 15, 1992Filed: Apr 15, 1992Granted: Aug 2, 1994
Est. expiryApr 15, 2012(expired)· nominal 20-yr term from priority
Inventors:Ching-Shih Chen
C12P 41/004C12P 13/02
51
PatentIndex Score
4
Cited by
7
References
2
Claims

Abstract

A computer modeling approach is taken to delineate the structural requirements of substrate molecules for biocatalytic turnover and enantioselective discrimination. This leads to an efficient enzymatic preparation of optically active propranolol. The acyl-sustituents on the alcohol and the secondary amine of propranolol play crucial roles in controlling the catalysis and enantiospecificity, respectively, of the enzymatic hydrolysis.

Claims

exact text as granted — not AI-modified
Having described my invention, what I now claim is: 
     
       1. A method for the synthesis of an enzymatic optically active propranolol which comprises: effecting an enzyme mediated enantioselective hydrolysis on a substrate of the formula: ##STR4## wherein the hydrolytic enzyme is cholesterol esterase, pig liver esterase or porcine pancrease esterase to form the corresponding (R) and (S) enantiomers;   separating the diasteroisomers; and   recovering the separated diasteroisomers.   
     
     
       2. The method of claim 1 which includes: converting the separated (S) enantiomer to ##STR5##

Join the waitlist — get patent alerts

Track US5334534A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.